OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, announced it has secured £1.8 million in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures, and Panacea Ventures.